Top Vaccines companies in United Kingdom by Debt to Equity Ratio

This ranking features the top 18 Vaccines companies in United Kingdom ranked by Debt to Equity Ratio, averaging a Debt to Equity Ratio of 0.87, for February 05, 2025.
#
Name
Debt to Equity Ratio
Reported Date
Stock Price
Change
Price (30 days) Country
1
8.35
June 30, 2024 USD 0.07 -16.83%

United Kingdom

2
8.07
Aug. 31, 2023 USD 0.13 4.36%

United Kingdom

3
0.53
June 30, 2024 USD 23.61 -1.99%

United Kingdom

4
0.48
Dec. 31, 2023 USD 2.21 0.46%

United Kingdom

5
0.37
Dec. 31, 2023 USD 0.24 -0.40%

United Kingdom

6
0.36
Dec. 31, 2023 USD 16.92 0.06%

United Kingdom

7
0.23
Dec. 31, 2023 USD 0.05 1.59%

United Kingdom

8
0.23
Dec. 31, 2023 USD 32.88 0.83%

United Kingdom

9
0.13
Dec. 31, 2023 USD 1.16 -5.69%

United Kingdom

10
0.12
Dec. 31, 2023 USD 13.39 4.86%

United Kingdom

11
0.12
Dec. 31, 2023 USD 3.01 2.73%

United Kingdom

12
0.08
March 31, 2024 USD 11.13 -2.11%

United Kingdom

13
0.05
March 31, 2024 USD 0.80 0.38%

United Kingdom

14
0.04
March 31, 2024 USD 1.69 NA

United Kingdom

15
0.04
Dec. 31, 2023 USD 0.70 -3.05%

United Kingdom

16
0.02
Dec. 31, 2023 USD 5.33 1.52%

United Kingdom

17
-4.39
Dec. 31, 2023 USD 0.05 -13.11%

United Kingdom

18
-21.25
Dec. 31, 2023 USD 14.61 -1.71%

United Kingdom

Frequently Asked Questions
  • Which Vaccines company in United Kingdom has the highest Debt to Equity Ratio ?

    The Vaccines company in United Kingdom with the highest Debt to Equity Ratio is Allergy Therapeutics plc (LSE: AGY.L) at 8.35.

  • Which Vaccines company in United Kingdom has the lowest Debt to Equity Ratio ?

    The Vaccines company in United Kingdom with the lowest Debt to Equity Ratio is 4basebio PLC (LSE: 4BB.L) at -21.25.

SV Wall Street